International Journal of Diseases and Disorders

ISSN 2329-9835

International Journal of Diseases and Disorders ISSN 2329-9835 Vol. 6 (5), pp. 001-006, May, 2018. © International Scholars Journals

Full Length Research Paper

Prevalence of multi-drug resistant pathogen isolated from high vaginal swab in Nigeria

Adegoke Caleb Oladele1, Deji-Agboola Anontu Mopelola2 and Ogunbanwo Samuel Temitope3*

1Department of Medical Laboratory Technology, Ogun State College of Health Technology, Ilese, Ijebu, Nigeria.

2Department of Medical Microbiology and Paresitology, Obafemi Awolowo College of Health Science, Olabisi Onabanjo University, Ago Iwoye, Nigeria.

3Department of Microbiology, Faculty of Science, University of Ibadan, Nigeria.

Accepted 12 October, 2017

Abstract

Samples of 262 high vaginal swabs collected from patients attending Ogun State College of Health Technology, Ilese-Ijebu were screened for sexually transmitted diseases (STDs) pathogen and antimicrobial susceptibility pattern. Micro-organisms isolated from these samples include; Niesseria gonorrhea, Staphylococcus aureus, Gardnerella vaginalis, Candida albican and Escherichia coli. Age group 21 to 25 had the highest occurrence of pathogens. About 81.8% of the pathogens isolated showed resistance to five or more antibiotics while 6.81% showed resistance to one antibiotic. S. aureus was found to be the most sensitive when tested against Ofloxacine and Nitrofuratoin with 25 zone of inhibition. G. vaginalis had minimum inhibitory concentration (MIC) ranging from 32 to 128 µg/ml while N. gonorrhea had MIC ranging from 16 to 512 µg/ml when tested a gainst tetracycline, ampiclause, ampicilline, gentamycin and augmentin. G. vaginalis had minimum bactericidal concentration (MBC) ranging from 32 to 128 µglml fo r tetracycline, nitrofuratoin, ampicilline, ampiclause and metronidazole while N. gonorrhea had MBC of 32 µg/ml for tetracycline and 512 µg/ml for ampicilline, ampiclause and gentamycin. Since micro-organisms continue to develop resistant to antibiotics, constant antimicrobial surveillance required to provide safety and effective therapy.

Key words: Antibiotics, STD pathogens, multi-drug resistance, minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC).